BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17579771)

  • 1. Transcriptomic signatures in breast cancer.
    Fu J; Jeffrey SS
    Mol Biosyst; 2007 Jul; 3(7):466-72. PubMed ID: 17579771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic applications of gene expression signatures in breast cancer.
    Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
    Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].
    Bertucci F; Viens P; Birnbaum D
    Pathol Biol (Paris); 2006 Feb; 54(1):49-54. PubMed ID: 16376179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
    Lancashire LJ; Rees RC; Ball GR
    Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarrays in breast cancer research and clinical practice--the future lies ahead.
    Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
    Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA microarray-based transcriptomic profiling of an isogenic cell culture model of breast tumour cell invasion.
    Hughes L; O'Brien SL; Gallagher WM; Mcdonnell S
    Anticancer Res; 2007; 27(3A):1353-9. PubMed ID: 17593630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cDNA microarray analysis of inflammatory breast cancer signatures.
    Laere SJ; Vermeulen PB; Dirix LY
    Methods Mol Biol; 2009; 512():71-98. PubMed ID: 19347274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene expression profiling using cDNA arrays and prognosis of breast cancer].
    Bertucci F; Nasser V; Houlgatte R; Birnbaum D
    Bull Cancer; 2002 Jun; 89(6):571-4. PubMed ID: 12135856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Has the time arrived for gene expression use at the bedside?].
    D'Hondt V; Piccart M; Sotiriou C
    Bull Cancer; 2008 Mar; 95(3):336-43. PubMed ID: 18390414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histopathologic diagnosis of luminal and basal type breast cancer].
    Sarcević B
    Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
    Calabrò A; Beissbarth T; Kuner R; Stojanov M; Benner A; Asslaber M; Ploner F; Zatloukal K; Samonigg H; Poustka A; Sültmann H
    Breast Cancer Res Treat; 2009 Jul; 116(1):69-77. PubMed ID: 18592372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomic hybridisation arrays: high-throughput tools to determine targeted therapy in breast cancer.
    Tan DS; Reis-Filho JS
    Pathobiology; 2008; 75(2):63-74. PubMed ID: 18544961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Agency for Research on Cancer workshop on 'Expression array analyses in breast cancer taxonomy'.
    Tavtigian SV; Pierotti MA; Børresen-Dale AL
    Breast Cancer Res; 2006; 8(6):303. PubMed ID: 17096863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microrevolution: applications and impacts of microarray technology on molecular biology and medicine (review).
    Goldsmith ZG; Dhanasekaran N
    Int J Mol Med; 2004 Apr; 13(4):483-95. PubMed ID: 15010847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When will tumor gene expression profiling be incorporated into clinical breast cancer decision making?
    Creighton CJ; Rae JM
    Breast Cancer Res; 2006; 8(4):302. PubMed ID: 16834787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.